265 related articles for article (PubMed ID: 32387631)
21. Low-Dose Acitretin for Secondary Prevention of Keratinocyte Carcinomas in Solid-Organ Transplant Recipients.
Solomon-Cohen E; Reiss-Huss S; Hodak E; Davidovici B
Dermatology; 2022; 238(1):161-166. PubMed ID: 33902035
[TBL] [Abstract][Full Text] [Related]
22. Management of non-melanoma skin cancer in solid organ transplant recipients.
Specchio F; Saraceno R; Chimenti S; Nistico S
Int J Immunopathol Pharmacol; 2014; 27(1):21-4. PubMed ID: 24674675
[TBL] [Abstract][Full Text] [Related]
23. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
[TBL] [Abstract][Full Text] [Related]
24. Periocular actinic keratosis, keratinocyte carcinomas, and eyeglasses use.
Lee KC; Weinstock MA;
J Am Acad Dermatol; 2013 Jul; 69(1):165-7. PubMed ID: 23768294
[No Abstract] [Full Text] [Related]
25. Nicotinamide: New Indications in Dermatology.
Escudero-Góngora MM; Fernández-Peñas P
Actas Dermosifiliogr; 2016 Nov; 107(9):777-778. PubMed ID: 27377936
[No Abstract] [Full Text] [Related]
26. Sunscreens in organ transplant patients.
Ulrich C; Degen A; Patel MJ; Stockfleth E
Nephrol Dial Transplant; 2008 Jun; 23(6):1805-8. PubMed ID: 18492979
[No Abstract] [Full Text] [Related]
27. The epidemiology of transplant-associated keratinocyte cancers in different geographical regions.
Proby CM; Wisgerhof HC; Casabonne D; Green AC; Harwood CA; Bouwes Bavinck JN
Cancer Treat Res; 2009; 146():75-95. PubMed ID: 19415194
[No Abstract] [Full Text] [Related]
28. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.
Massey PR; Schmults CD; Li SJ; Arron ST; Asgari MM; Bouwes Bavinck JN; Billingsley E; Blalock TW; Blasdale K; Carroll BT; Carucci JA; Chong AH; Christensen SR; Chung CL; DeSimone JA; Ducroux E; Escutia-Muñoz B; Ferrándiz-Pulido C; Fox MC; Genders RE; Geusau A; Gjersvik P; Hanlon AM; Olasz Harken EB; Hofbauer GFL; Hopkins RS; Leitenberger JJ; Loss MJ; Del Marmol V; Mascaró JM; Myers SA; Nguyen BT; Oliveira WRP; Otley CC; Proby CM; Rácz E; Ruiz-Salas V; Samie FH; Seçkin D; Shah SN; Shin TM; Shumack SP; Soon SL; Stasko T; Zavattaro E; Zeitouni NC; Zwald FO; Harwood CA; Jambusaria-Pahlajani A
JAMA Dermatol; 2021 Oct; 157(10):1219-1226. PubMed ID: 34468690
[TBL] [Abstract][Full Text] [Related]
29. Skin cancer: Nicotinamide reduces new skin cancer risk.
Sidaway P
Nat Rev Clin Oncol; 2016 Jan; 13(1):4. PubMed ID: 26525684
[No Abstract] [Full Text] [Related]
30. Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.
Zamoiski RD; Yanik E; Gibson TM; Cahoon EK; Madeleine MM; Lynch CF; Gustafson S; Goodman MT; Skeans M; Israni AK; Engels EA; Morton LM
Cancer Res; 2017 Aug; 77(15):4196-4203. PubMed ID: 28615224
[TBL] [Abstract][Full Text] [Related]
31. Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis.
Mainville L; Smilga AS; Fortin PR
J Cutan Med Surg; 2022; 26(3):297-308. PubMed ID: 35134311
[TBL] [Abstract][Full Text] [Related]
32. Nicotinamide found to reduce the rate of nonmelanoma skin cancers in high-risk patients.
Barton MK
CA Cancer J Clin; 2016; 66(2):91-2. PubMed ID: 26754863
[No Abstract] [Full Text] [Related]
33. Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature.
Lowenstein SE; Garrett G; Toland AE; Jambusaria-Pahlajani A; Asgari MM; Green A; Engels EA; Arron ST;
Br J Dermatol; 2017 Nov; 177(5):1202-1207. PubMed ID: 28952162
[TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.
Neugebauer R; Su KA; Zhu Z; Sokil M; Chren MM; Friedman GD; Asgari MM
J Am Acad Dermatol; 2019 Apr; 80(4):998-1005. PubMed ID: 30458208
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic options to decrease actinic keratosis and squamous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach.
Ritchie SA; Patel MJ; Miller SJ
Dermatol Surg; 2012 Oct; 38(10):1604-21. PubMed ID: 22646842
[TBL] [Abstract][Full Text] [Related]
36. [Non-melanoma skin cancer : Pathogenesis, prevalence and prevention].
Zink A
Hautarzt; 2017 Nov; 68(11):919-928. PubMed ID: 29018888
[TBL] [Abstract][Full Text] [Related]
37. Current Practices for Preventative Interventions for Nonmelanoma Skin Cancers Among Dermatologic Surgeons.
Arzeno J; Leavitt E; Lonowski S; Kim J
Dermatol Surg; 2021 Jul; 47(7):995-997. PubMed ID: 33587370
[No Abstract] [Full Text] [Related]
38. ACP Journal Club. In high-risk patients, oral nicotinamide reduced number of new nonmelanoma skin cancers during treatment.
Hajdenberg J
Ann Intern Med; 2016 Feb; 164(4):JC18. PubMed ID: 26882303
[No Abstract] [Full Text] [Related]
39. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients.
De Graaf YG; Euvrard S; Bouwes Bavinck JN
Dermatol Surg; 2004 Apr; 30(4 Pt 2):656-61. PubMed ID: 15061851
[TBL] [Abstract][Full Text] [Related]
40. Nicotinamide for skin cancer chemoprevention.
Damian DL
Australas J Dermatol; 2017 Aug; 58(3):174-180. PubMed ID: 28321860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
